| Date | Title | Description | Source |
| 04.04.2024 | The CEO of a weight-loss ETF that's crushing the S&P 500... | Markets The CEO of a weight-loss ETF that's crushing the S&P 500 since launching in November sha... | businessin... |
| 17.03.2024 | Weight loss drugs like Ozempic and Wegovy are fattening up D... | Economy Weight loss drugs like Ozempic and Wegovy are fattening up Denmark's economy and helped it d... | businessin... |
| 13.03.2024 | New Employee Elected Directors to the Board of Zealand Pharm... | - | globenewsw... |
| 08.03.2024 | Transactions in Zealand Pharma shares and/or related securit... | - | globenewsw... |
| 05.03.2024 | Transactions in Zealand Pharma shares and/or related securit... | - | globenewsw... |
| 05.03.2024 | Zealand Pharma Increases its Share Capital as a Consequence ... | - | globenewsw... |
| 22.12.2023 | Zealand Pharma enters into EUR 90 million finance agreement ... | - | globenewsw... |
| 18.09.2023 | Is Denmark Setting the Global Standard in Peptide-Based Biop... | Key Takeaways:
Zealand Pharma, based in Denmark, is a leader in peptide-based biopharmaceutical inno... | eustartup.... |
| 17.08.2023 | Zealand Pharma Announces Financial Results for the First Hal... | Company announcement - No. 28 / 2023
Zealand Pharma Announces Financial Results for the First Half o... | einpresswi... |
| 30.06.2023 | Zealand Pharma submits New Drug Application to US FDA for da... | /EIN News/ -- Press release – No. 8 / 2023
Zealand Pharma submits New Drug Application to US FDA for... | einpresswi... |
| 11.10.2022 | Zealand Pharma major shareholder announcement: Polar Capital | Company announcement – No. 47 / 2022
Zealand Pharma major shareholder announcement: Polar Capital
Co... | globenewsw... |
| 10.10.2022 | Zealand Pharma major shareholder announcement: Van Herk Inve... | /EIN News/ -- Company announcement – No. 46 / 2022
Zealand Pharma major shareholder announcement: Va... | einpresswi... |
| 10.10.2022 | Zealand Pharma major shareholder announcement: Van Herk Inve... | Company announcement – No. 46 / 2022
Zealand Pharma major shareholder announcement: Van Herk Investm... | globenewsw... |
| 13.09.2022 | Zealand Pharma grants warrants to employees in Denmark | Company announcement – No. 40 / 2022
Zealand Pharma grants warrants to employees in Denmark
Copenhag... | globenewsw... |
| 30.06.2022 | Total number of shares and voting rights in Zealand Pharma a... | Company announcement – No. 30 / 2022
Total number of shares and voting rights in Zealand Pharma at J... | globenewsw... |
| 10.06.2022 | Zealand Pharma major shareholder announcement: Credit Suisse... | Company announcement – No. 28 / 2022
Zealand Pharma major shareholder announcement: Credit Suisse Gr... | globenewsw... |
| 19.05.2022 | Zealand Pharma Announces Positive Results from Phase 3 Trial... | Company announcement – No. 22 / 2022
Zealand Pharma Announces Positive Results from Phase 3 Trial of... | globenewsw... |
| 10.05.2022 | Zealand Pharma major shareholder announcement: Credit Suisse... | Company announcement – No. 17 / 2022
Zealand Pharma major shareholder announcement: Credit Suisse Gr... | globenewsw... |
| 07.04.2022 | Zealand Pharma major shareholder announcement: The Capital G... | Company announcement – No. 13 / 2022
Zealand Pharma major shareholder announcement: The Capital Grou... | globenewsw... |
| 07.04.2022 | Correction: Zealand Pharma major shareholder announcement: P... | Company announcement – No. 13 / 2022
CORRECTION: Zealand Pharma major shareholder announcement: Pola... | globenewsw... |
| 30.03.2022 | Zealand Pharma Appoints New Chief Executive Officer, Refocus... | Company announcement – No. 10 / 2022
Zealand Pharma Appoints New Chief Executive Officer, Refocuses ... | globenewsw... |
| 11.03.2022 | Correction: Zealand Pharma: Significant Advancement of Clini... | Company announcement – No. 9 / 2022
Zealand Pharma: Significant Advancement of Clinical Pipeline and... | globenewsw... |
| 10.03.2022 | Zealand Pharma: Significant Advancement of Clinical Pipeline... | Company announcement – No. 7 / 2022
Zealand Pharma: Significant Advancement of Clinical Pipeline and... | globenewsw... |
| 25.02.2022 | Zealand Pharma major shareholder announcement: The Capital G... | Company announcement – No. 5 / 2022
Zealand Pharma major shareholder announcement: The Capital Group... | globenewsw... |
| 20.01.2022 | Zealand Pharma Completes Enrollment in EASE-SBS 1 Phase 3 Tr... | Company announcement – No. 3 / 2022
Zealand Pharma Completes Enrollment in EASE-SBS 1 Phase 3 Trial ... | globenewsw... |
| 19.01.2022 | Zealand Pharma major shareholder announcement: The Capital G... | Company announcement – No. 2 / 2021
Zealand Pharma major shareholder announcement: The Capital Group... | globenewsw... |
| 19.01.2022 | Zealand Pharma major shareholder announcement: The Capital G... | Company announcement – No. 2 / 2021
Zealand Pharma major shareholder announcement: The Capital Group... | marketscre... |
| 30.12.2021 | Total number of shares and voting rights in Zealand Pharma a... | Company announcement – No. 78 / 2021
Total number of shares and voting rights in Zealand Pharma at D... | globenewsw... |
| 24.12.2021 | Zealand Pharma major shareholder announcement: The Capital G... | Company announcement – No. 77 / 2021
Zealand Pharma major shareholder announcement: The Capital Grou... | globenewsw... |
| 24.12.2021 | Zealand Pharma major shareholder announcement: The Capital G... | Company announcement – No. 77 / 2021
Zealand Pharma major shareholder announcement: The Capital Grou... | marketscre... |
| 16.12.2021 | Zealand Pharma Announces Enrollment of Last Patient Needed f... | Company announcement – No. 76 / 2021
Zealand Pharma Announces Enrollment of Last Patient Needed for ... | globenewsw... |
| 16.12.2021 | Zealand Pharma A/S : Announces Seven-Year, $200 Million Fina... | Zealand Pharma Announces Seven-Year, $200 Million Financing Agreement with Oberland Capital
· Agreem... | marketscre... |
| 16.12.2021 | Zealand Pharma Announces Enrollment of Last Patient Needed f... | Company announcement – No. 76 / 2021
Zealand Pharma Announces Enrollment of Last Patient Needed for ... | marketscre... |
| 14.12.2021 | Zealand Pharma Announces Seven-Year, $200 Million Financing ... | Company announcement – No. 75 / 2021
Zealand Pharma Announces Seven-Year, $200 Million Financing Agr... | globenewsw... |
| 14.12.2021 | Zealand Pharma Announces Seven-Year, $200 Million Financing ... | Company announcement – No. 75 / 2021
Zealand Pharma Announces Seven-Year, $200 Million Financing Agr... | marketscre... |
| 10.12.2021 | Zealand Pharma increases its share capital as a consequence ... | Company announcement – No. 74 / 2021
Zealand Pharma increases its share capital as a consequence of ... | globenewsw... |
| 10.12.2021 | Zealand Pharma increases its share capital as a consequence ... | Company announcement – No. 74 / 2021
Zealand Pharma increases its share capital as a consequence of ... | marketscre... |
| 30.11.2021 | Zealand Pharma major shareholder announcement: The Capital G... | Company announcement – No. 73 / 2021
Zealand Pharma major shareholder announcement: The Capital Grou... | globenewsw... |
| 30.11.2021 | Total number of shares and voting rights in Zealand Pharma a... | Company announcement – No. 72 / 2021
Total number of shares and voting rights in Zealand Pharma at N... | globenewsw... |
| 30.11.2021 | Zealand Pharma major shareholder announcement: The Capital G... | Company announcement – No. 73 / 2021
Zealand Pharma major shareholder announcement: The Capital Grou... | marketscre... |
| 29.11.2021 | Zealand Pharma major shareholder announcement: Credit Suisse... | Company announcement – No. 71 / 2021
Zealand Pharma major shareholder announcement: Credit Suisse Gr... | globenewsw... |
| 29.11.2021 | Zealand Pharma major shareholder announcement: Credit Suisse... | Company announcement – No. 71 / 2021
Zealand Pharma major shareholder announcement: Credit Suisse Gr... | marketscre... |
| 23.11.2021 | Zealand Pharma A/S : announces successful outcome of Phase 1... | Zealand Pharma announces successful outcome of Phase 1b clinical trial with GLP1-GLP2 dual receptor ... | marketscre... |
| 20.11.2021 | Zealand Pharma A/S : Company announcement – No. 69/ 2021 Com... | Company announcement - No. 69/ 2021
Company announcement - No. 69 / 2021 Zealand Pharma increases it... | marketscre... |
| 19.11.2021 | Zealand Pharma increases its share capital as a consequence ... | Company announcement – No. 69/ 2021
Zealand Pharma increases its share capital as a consequence of e... | marketscre... |
| 12.11.2021 | Zealand Pharma Presents Financial Results for the First Nine... | Zealand Pharma Presents Financial Results for the First Nine Months of 2021; Provides Updates on Com... | marketscre... |
| 12.11.2021 | Zealand Pharma to Participate in Jefferies London Healthcare... | Company announcement – No. 68 / 2021
Zealand Pharma to Participate in Jefferies London Healthcare Co... | globenewsw... |
| 11.11.2021 | Zealand Pharma Presents Financial Results for the First Nine... | Company announcement – No. 67/ 2021
Interim report for 9M 2021
Zealand Pharma Presents Financial Res... | marketscre... |
| 11.11.2021 | Zealand Pharma Presents Financial Results for the First Nine... | Company announcement – No. 67/ 2021
Interim report for 9M 2021
Zealand Pharma Presents Financial Res... | globenewsw... |
| 04.11.2021 | Zealand Pharma Hosts Conference Call on November 11 at 4 pm ... | Company announcement – No. 64 / 2021
Zealand Pharma Hosts Conference Call on November 11 at 4 pm CET... | globenewsw... |
| 04.11.2021 | Zealand Pharma Announces First Subject Dosed in Phase 1 Tria... | Company announcement – No. 65/ 2021
Zealand Pharma Announces First Subject Dosed in Phase 1 Trial of... | marketscre... |
| 01.11.2021 | Zealand Pharma Announces Presentation of Preclinical Data on... | Company announcement – No. 63 / 2021
Zealand Pharma Announces Presentation of Preclinical Data on Am... | marketscre... |
| 01.11.2021 | Zealand Pharma Announces Presentation of Preclinical Data on... | Company announcement – No. 63 / 2021
Zealand Pharma Announces Presentation of Preclinical Data on Am... | globenewsw... |
| 19.08.2021 | Zealand Pharma Announces First Patient Dosed in EASE-SBS 4 P... | Company announcement – No. 52 / 2021
Zealand Pharma Announces First Patient Dosed in EASE-SBS 4 Phas... | marketscre... |
| 12.08.2021 | Zealand Pharma Launches ZEGALOGUE® (dasiglucagon) Injection ... | Company annoucement - No. 50 / 2021
Interim report for H1 2021
Zealand Pharma Launches ZEGALOGUE® (d... | marketscre... |
| 24.06.2021 | Zealand Pharma Announces U.S. Commercial Availability of ZEG... | Company announcement – No. 41/ 2021
Zealand Pharma Announces U.S. Commercial Availability of ZEGALOG... | marketscre... |
| 16.06.2021 | ZEALAND PHARMA A/S
Zealand Pharma to Present Data on Glucag... | Company announcement – No. 39/2021
Zealand Pharma to Present Data on Glucagon Analog, Dasiglucagon, ... | marketscre... |
| 02.06.2021 | ZEALAND PHARMA A/S
Boehringer Ingelheim and Zealand Pharma ... | Company announcement – No. 35/ 2021
Boehringer Ingelheim and Zealand Pharma Receive FDA Fast Track D... | marketscre... |
| 01.06.2021 | Minutes from the Extraordinary General Meeting in Curasight ... | Minutes from the Extraordinary General Meeting in Curasight A/S Tue, Jun 01, 2021 12:01 CET
Curasigh... | news.cisio... |
| 27.05.2021 | ZEALAND PHARMA A/S
Zealand Pharma A/S : launches long-term ... | Company announcement – No. 33 / 2021
Zealand Pharma launches long-term incentive program for Zealand... | marketscre... |
| 18.05.2021 | Notice of Extraordinary General Meeting | Notice of Extraordinary General Meeting Tue, May 18, 2021 13:00 CET
Copenhagen, Denmark, 18 May 2021... | news.cisio... |
| 12.05.2021 | ZEALAND PHARMA A/S
Zealand Pharma A/S : launches long-term ... | Company announcement – No. 28/ 2021
Zealand Pharma launches long-term incentive program for Zealand’... | marketscre... |
| 29.04.2021 | ZEALAND PHARMA A/S
Zealand Pharma A/S : launches long-term ... | Company announcement – No. 23 / 2021
Zealand Pharma launches long-term incentive program for Zealand... | marketscre... |
| 10.08.2017 | Zealand bags a $77M IPO haul as investors embrace anothe... | Copenhagen-based Zealand Pharma is the latest biotech to march out onto Nasdaq this year. The p... | endpts.com... |
| 09.08.2017 | Term Sheet — Wednesday, Aug. 9 | ET CETERA
Good morning! I’m attending to some magazine duties today, so here’s some news from my For... | fortune.co... |
| 03.08.2017 | Term Sheet — Thursday, Aug. 3 | MARKDOWNS AGAIN
After we wrote about mutual fund markdowns to Uber’s share price, a few readers wrot... | fortune.co... |
| 07.07.2017 | Zealand Pharma blueprints an $86M IPO on Nasdaq as it ma... | Copenhagen-based Zealand Pharma is following a clearly blazed trail from Europe to Nasdaq in ... | endpts.com... |
